Resuming elective hip and knee arthroplasty after the first phase of the SARS-CoV-2 pandemic: the European Hip Society and European Knee Associates recommendations - Takeaways - MDSpire

Resuming elective hip and knee arthroplasty after the first phase of the SARS-CoV-2 pandemic: the European Hip Society and European Knee Associates recommendations

  • By

  • N. P. Kort

  • E. Gómez Barrena

  • M. Bédard

  • S. Donell

  • J.-A. Epinette

  • B. Gomberg

  • M. T. Hirschmann

  • P. Indelli

  • Ismail Khosravi

  • T. Karachalios

  • M. C. Liebensteiner

  • B. Stuyts

  • R. Tandogan

  • B. Violante

  • L. Zagra

  • M. Thaler

  • August 25, 2020

  • 0 min

Share

  • 1

    The SARS-CoV-2 pandemic significantly reduced elective hip and knee arthroplasties across Europe, necessitating a consensus on safe resumption.

  • 2

    Delaying arthroplasty in patients with severe osteoarthritis can worsen outcomes, increase opioid use, and elevate healthcare costs.

  • 3

    The European Hip Society and European Knee Association developed recommendations for safely restarting elective arthroplasty based on expert consensus.

  • 4

    New triage criteria and enhanced recovery protocols are essential for prioritizing patients and ensuring safety during elective surgeries.

  • 5

    Post-operative care strategies, including telemedicine and home care, are crucial for managing patient recovery and minimizing infection risk.

Original Source(s)

Related Content